Top Header Menu

Tag Archives | Varenicline

Curt D. Furberg, M.D., Ph.D.

Chantix Is Unsuitable For First-Line Smoking Cessation Use

The poor safety profile of the smoking-cessation drug varenicline (Chantix™) makes it unsuitable for first-line use, according to a study published in the Nov. 2 edition of the journal PLoS One, an online publication of the Public Library of Science. Varenicline, which already carries a “black box warning” from the U.S. Food and Drug Administration (FDA), […]

Continue Reading 0
a patient entering a PET scan

Brain Imaging Studies Examine How Anti-Smoking Medications May Curb Cravings

The smoking cessation medications bupropion and varenicline may both be associated with changes in the way the brain reacts to smoking cues, making it easier for patients to resist cravings, according to two reports posted online today that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Continue Reading 0

Proudly hosted by Lightning Base